United States · Platforms & data · Morningstar
DSS, Inc. Announces SEC Declaration of Effectiveness of Form F-4 Registration Statement, Marking Major Milestone Toward Closing of Proposed Business Combination
ROCHESTER, NY / ACCESS Newswire / November 2, 2026 / DSS, Inc. (NYSE American:DSS) ("DSS"), majority shareholder of Impact Biomedical Inc. (NYSE American:IBO ...
Read the full article on Morningstar Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.morningstar.com)




